Literature DB >> 33510429

Predicting the probability of Gaucher disease in subjects with splenomegaly and thrombocytopenia.

Irene Motta1,2, Dario Consonni3, Marina Stroppiano4, Christian Benedetto5, Elena Cassinerio1, Barbara Tappino4, Paola Ranalli6, Lorenza Borin7, Luca Facchini8, Andrea Patriarca9, Wilma Barcellini10, Federica Lanza4, Mirella Filocamo4, Maria Domenica Cappellini11,12.   

Abstract

Hematologists are frequently involved in the diagnostic pathway of Gaucher disease type 1 (GD1) patients since they present several hematological signs. However, GD1 is mainly underdiagnosed because of a lack of awareness. In this multicenter study, we combine the use of a diagnostic algorithm with a simple test (β-glucosidase activity on Dried Blood Spot) in order to facilitate the diagnosis in a population presenting to the hematologist with splenomegaly and/or thrombocytopenia associated with other hematological signs. In this high-risk population, the prevalence of GD1 is 3.3%. We propose an equation that predicts the probability of having GD1 according to three parameters that are routinely evaluated: platelet count, ferritin, and transferrin saturation.

Entities:  

Year:  2021        PMID: 33510429     DOI: 10.1038/s41598-021-82296-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  22 in total

1.  The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease.

Authors:  J Charrow; H C Andersson; P Kaplan; E H Kolodny; P Mistry; G Pastores; B E Rosenbloom; C R Scott; R S Wappner; N J Weinreb; A Zimran
Journal:  Arch Intern Med       Date:  2000-10-09

2.  An improved high-throughput dried blood spot screening method for Gaucher disease.

Authors:  Petra Olivova; Emmaline Cullen; Mariah Titlow; Helmut Kallwass; John Barranger; Kate Zhang; Joan Keutzer
Journal:  Clin Chim Acta       Date:  2008-09-09       Impact factor: 3.786

3.  Gaucher disease screening at a general adult hematology tertiary care centre: A prospective study.

Authors:  Steven A Russell; Michelle Sholzberg; Joy Mangel; Michael Keeney; Ben Hedley; Margo Bode; Alan Gob; Selay Lam; Chai Phua; Cyrus C Hsia
Journal:  Int J Lab Hematol       Date:  2018-12-04       Impact factor: 2.877

4.  A multicentre observational study for early diagnosis of Gaucher disease in patients with Splenomegaly and/or Thrombocytopenia.

Authors:  Irene Motta; Mirella Filocamo; Erika Poggiali; Marina Stroppiano; Alfredo Dragani; Dario Consonni; Wilma Barcellini; Gianluca Gaidano; Luca Facchini; Giorgina Specchia; Maria Domenica Cappellini
Journal:  Eur J Haematol       Date:  2015-06-11       Impact factor: 2.997

5.  Newborn screening for lysosomal storage disorders by tandem mass spectrometry in North East Italy.

Authors:  Alberto B Burlina; Giulia Polo; Leonardo Salviati; Giovanni Duro; Carmela Zizzo; Andrea Dardis; Bruno Bembi; Chiara Cazzorla; Laura Rubert; Roberta Zordan; Robert J Desnick; Alessandro P Burlina
Journal:  J Inherit Metab Dis       Date:  2017-11-15       Impact factor: 4.982

6.  Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physicians.

Authors:  Atul Mehta; Nadia Belmatoug; Bruno Bembi; Patrick Deegan; Deborah Elstein; Özlem Göker-Alpan; Elena Lukina; Eugen Mengel; Kimitoshi Nakamura; Gregory M Pastores; Jordi Pérez-López; Ida Schwartz; Christine Serratrice; Jeffrey Szer; Ari Zimran; Maja Di Rocco; Zoya Panahloo; David J Kuter; Derralynn Hughes
Journal:  Mol Genet Metab       Date:  2017-08-04       Impact factor: 4.797

7.  A reappraisal of Gaucher disease-diagnosis and disease management algorithms.

Authors:  Pramod K Mistry; Maria Domenica Cappellini; Elena Lukina; Hayri Ozsan; Sara Mach Pascual; Hanna Rosenbaum; Maria Helena Solano; Zachary Spigelman; Jesús Villarrubia; Nora Patricia Watman; Gero Massenkeil
Journal:  Am J Hematol       Date:  2011-01       Impact factor: 10.047

8.  Consequences of diagnostic delays in type 1 Gaucher disease: the need for greater awareness among hematologists-oncologists and an opportunity for early diagnosis and intervention.

Authors:  Pramod K Mistry; Sara Sadan; Ruhua Yang; John Yee; Mei Yang
Journal:  Am J Hematol       Date:  2007-08       Impact factor: 10.047

9.  Diagnosing Gaucher disease: an on-going need for increased awareness amongst haematologists.

Authors:  A S Thomas; A B Mehta; D A Hughes
Journal:  Blood Cells Mol Dis       Date:  2012-12-06       Impact factor: 3.039

10.  Validity of β-D-glucosidase activity measured in dried blood samples for detection of potential Gaucher disease patients.

Authors:  Marina Stroppiano; Maria Grazia Calevo; Fabio Corsolini; Michela Cassanello; Elena Cassinerio; Federica Lanza; Giorgia Stroppiana; Maria Domenica Cappellini; Mirella Filocamo
Journal:  Clin Biochem       Date:  2014-06-16       Impact factor: 3.281

View more
  3 in total

1.  C-X-C Motif Chemokine Ligand 9 and Its CXCR3 Receptor Are the Salt and Pepper for T Cells Trafficking in a Mouse Model of Gaucher Disease.

Authors:  Albert Frank Magnusen; Reena Rani; Mary Ashley McKay; Shelby Loraine Hatton; Tsitsi Carol Nyamajenjere; Daniel Nii Aryee Magnusen; Jörg Köhl; Gregory Alex Grabowski; Manoj Kumar Pandey
Journal:  Int J Mol Sci       Date:  2021-11-24       Impact factor: 5.923

2.  Early diagnosis of Gaucher disease in Korean patients with unexplained splenomegaly: a multicenter observational study.

Authors:  Young Rok Do; Yunsuk Choi; Mi Hwa Heo; Jin Seok Kim; Jae-Ho Yoon; Je-Hwan Lee; Joon Seong Park; Sang Kyun Sohn; Sung Hyun Kim; Sungnam Lim; Joo Seop Chung; Deog-Yeon Jo; Hyeon Seok Eom; Hawk Kim; So Yeon Jeon; Jong-Ho Won; Hee Jeong Lee; Jung Won Shin; Jun-Ho Jang; Sung-Soo Yoon
Journal:  Blood Res       Date:  2022-07-27

3.  Screening for potential undiagnosed Gaucher disease patients: Utilisation of the Gaucher earlier diagnosis consensus point-scoring system (GED-C PSS) in conjunction with electronic health record data, tissue specimens, and small nucleotide polymorphism (SNP) genotype data available in Finnish biobanks.

Authors:  Minja Pehrsson; Hanna Heikkinen; Ulla Wartiovaara-Kautto; Sampo Mäntylahti; Pia Bäckström; Mariann I Lassenius; Kristiina Uusi-Rauva; Olli Carpén; Kaisa Elomaa
Journal:  Mol Genet Metab Rep       Date:  2022-08-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.